Home
Beam Therapeutics BEAM paid Aviva Strategies $51K for lobbying in Q4 2025 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $51,000
- Quarter
- Q4 2025
- Client
- Beam Therapeutics
- Reported
- 26/01/15
Up 0.0% from last quarter
What else happened in Beam Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Beam Therapeutics's other lobbying reports
- Beam Therapeutics
LobbyingBeam Therapeutics
LobbyingBeam Therapeutics
BEAM
Under $5,000
Under $5,000
Reported 07/17
for Q2
- Beam Therapeutics
LobbyingBeam Therapeutics
LobbyingBeam Therapeutics
BEAM
$10K
$10K
Reported 07/16
for Q2
- Beam Therapeutics
LobbyingBeam Therapeutics
LobbyingBeam Therapeutics
BEAM
$51K
$51K
Reported 25/10/15
for Q3 2025
- Beam Therapeutics
LobbyingBeam Therapeutics
LobbyingBeam Therapeutics
BEAM
Under $5,000
Under $5,000
Reported 25/07/16
for Q2 2025